Pre-Open Stock Movers 09/09: (TRIL) (NLS) (TSLA) Higher; (WORK) (ANTX) (LULU) Lower (more...)
Get Alerts TRIL Hot Sheet
Join SI Premium – FREE
Today's Pre-Open Stock Movers:
Trillium Therapeutics Inc. (NASDAQ: TRIL) 42.7% HIGHER; announced that it has agreed to sell 2,297,794 of its common shares at a price of $10.88 per share to Pfizer Inc. (NYSE: PFE), for gross proceeds of $25.0 million (the Transaction). The common shares were offered and sold to Pfizer Inc. in a registered direct offering conducted without an underwriter or placement agent. The offering is expected to close on or about September 10, 2020.
Slack (NYSE: WORK) 18% LOWER; reported Q2 EPS of $0.00, $0.03 better than the analyst estimate of ($0.03). Revenue for the quarter came in at $215.9 million versus the consensus estimate of $209.1 million. Slack sees Q3 2021 EPS of ($0.06)-($0.05), versus the consensus of ($0.05). Slack sees Q3 2021 revenue of $222-225 million, versus the consensus of $223.73 million. Slack sees FY2021 EPS of ($0.14)-($0.13), versus the consensus of ($0.16). Slack sees FY2021 revenue of $870-876 million, versus the consensus of $873.3 million.
Nautilus (NYSE: NLS) 10% HIGHER; Citron Research said it is long and set a $30 price target.
Athenex, Inc. (Nasdaq: ATNX) 9.8% LOWER; intends to offer and sell, subject to market conditions, 10,000,000 shares of its common stock in an underwritten public offering.
Air Transport Services Group, Inc. (Nasdaq: ATSG) 9% HIGHER; announced that ATSG will operate six more Boeing 767 freighters on behalf of Amazon Air (NASDAQ: AMZN) under an existing CMI (Crew, Maintenance and Insurance) agreement with ATSG’s subsidiary, Airborne Global Solutions.
Tesla (NASDAQ: TSLA) 8% HIGHER; gains as it stabilizes from the recent sell-off.
lululemon athletica (NASDAQ: LULU) 6.4% LOWER; reported Q2 EPS of $0.74, $0.19 better than the analyst estimate of $0.55. Revenue for the quarter came in at $902.9 million versus the consensus estimate of $842.49 million.
AstraZeneca (NYSE: AZN) 6.3% LOWER; COVID19 vaccine study put on hold due to suspected adverse reaction in participant in the UK - STAT
Phreesia Inc. (NYSE: PHR) 6.2% LOWER; reported Q2 EPS of ($0.17), $0.04 worse than the analyst estimate of ($0.13). Revenue for the quarter came in at $35 million versus the consensus estimate of $31.62 million.
Qorvo (Nasdaq: QRVO) 6% HIGHER; raises Q2 guidance
Vroom, Inc. (Nasdaq: VRM) 5.4% LOWER; announced that it has commenced an underwritten public offering of its common stock. Vroom is offering 9,000,000 shares of its common stock pursuant to a registration statement on Form S-1 filed with the Securities and Exchange Commission (the SEC). Vroom expects to grant the underwriters a 30-day option to purchase up to an additional 1,350,000 shares of its common stock at the public offering price, less the underwriting discount.
Babcock & Wilcox (NYSE: BW) 5% HIGHER; sees insider buying from CEO and others
Virgin Galactic (NYSE: SPCE) 5% HIGHER; Credit Suisse reinstates coverage on with an Outperform rating and a price target of $24.00.
Stitch Fix, Inc. (NASDAQ: SFIX) 4.4% HIGHER; Deutsche Bank initiates coverage on with a Buy rating and a price target of $34.00.
Moderna, Inc. (NASDAQ: MRNA) 4% HIGHER; gains on AZN vaccine setback.
DraftKings Inc. (NASDAQ: DKNG) 3.7% HIGHER; Evercore ISI initiates coverage on with an Outperform rating and a price target of $60.00.
Novavax, Inc. (NASDAQ: NVAX) 3.7% HIGHER; gains on AZN vaccine setback.
Summit Materials (NYSE: SUM) 3.3% HIGHER; CEO, Anne Noona, bought 66,000 shares on 09/04 at $15.24.
Coupa Software (NASDAQ: COUP) 2.7% LOWER; reported Q2 EPS of $0.21, $0.13 better than the analyst estimate of $0.08. Revenue for the quarter came in at $125.9 million versus the consensus estimate of $118.84 million. Coupa Software sees Q3 2021 EPS of $0.02-$0.03, versus the consensus of $0.05. Coupa Software sees Q3 2021 revenue of $123-124 million, versus the consensus of $122.25 million. Coupa Software sees FY2021 EPS of $0.43-$0.45, versus the consensus of $0.38. Coupa Software sees FY2021 revenue of $496.5-498.5 million, versus the consensus of $491.2 million.
ARAMARK Holdings (NYSE: ARMK) 2.4% HIGHER; Goldman Sachs upgraded from Neutral to Buy with a price target of $36.00 (from $23.00).
Microsoft (NASDAQ: MSFT) 2.1% HIGHER; PT Increases to $245 at Morgan Stanley Ahead of Potential Dividend Hike Announcement
HealthEquity (NASDAQ: HQY) 1.8% LOWER; reported Q2 EPS of $0.42, $0.15 better than the analyst estimate of $0.27. Revenue for the quarter came in at $176 million versus the consensus estimate of $171.28 million. HealthEquity sees FY2021 EPS of $1.48-$1.58, versus the consensus of $1.44. HealthEquity sees FY2021 revenue of $720-730 million, versus the consensus of $733.4 million.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Fisker (FSR) files form 10-K, sees more job cuts, reiterates going concern doubts
- 10X Capital Venture Acquisition Corp. III (VCXB) Receives NYSE Notice Regarding Late Form 10-K Filing
- AZZ, Inc. (AZZ) Announces Proposed 4M Share Offering
Create E-mail Alert Related Categories
Special ReportsRelated Entities
Credit Suisse, Deutsche Bank, Goldman Sachs, Morgan Stanley, Citron Research, Dividend, Tesla, S1, Pre-Open Losers, Pre-Open Winners, Pre Market MoversSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!